Fulcrum Therapeutics® Reports Recent Business Highlights and Third Quarter 2021 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/28/2026

1. NVDA
2. SPCX
3. META
4. MDB
5. USO
6. MU
7. KOD
8. LLY
9. SPY
10. MIRM

Go back to Fulcrum Therapeutics® Reports Recent Business Highlights and Third Quarter 2021 Financial Results

Fulcrum Therapeutics Inc. (FULC) Tops Q3 EPS by 8c; Cash and Cash Equivalents of $240.3M

November 4, 2021 7:21 AM EDT

Fulcrum Therapeutics Inc. (NASDAQ: FULC) reported Q3 EPS of ($0.57), $0.08 better than the analyst estimate of ($0.65). Revenue for the quarter came in at $4.9 million versus the consensus estimate of $2.25 million.

For earnings history and earnings-related data on Fulcrum Therapeutics Inc. (FULC) click here.

... More